{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T22:18:46Z","timestamp":1771971526446,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Granulocyte colony\u2013stimulating factor (G-CSF) has raised much interest because of its role in cocaine addiction in preclinical models. We explored the plasma concentrations of G-CSF in patients diagnosed with substance use disorder (SUD) and highly comorbid psychiatric disorders. In particular, we investigated the association between G-CSF concentrations and comorbid major depressive disorder (MDD) in patients with cocaine and alcohol use disorders (CUD and AUD, respectively). Additionally, patients with MDD but not SUD were included in the study. Three hundred and eleven participants were enrolled in this exploratory study: 136 control subjects, 125 patients with SUD (SUD group) from outpatient treatment programs for cocaine (N\u2009=\u200960, cocaine subgroup) and alcohol (N\u2009=\u200965, alcohol subgroup), and 50 patients with MDD but not SUD (MDD group) from primary-care settings. Participants were assessed based on DSM-IV-TR criteria, and a blood sample was collected to examine the plasma concentrations of G-CSF. G-CSF concentrations were negatively correlated with age in the entire sample (r\u2009=\u2009\u2212\u20090.233, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) but not in the patients with MDD. G-CSF concentrations were lower in patients with SUD than in controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), specifically in the cocaine subgroup (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Patients with SUD and comorbid MDD had lower G-CSF concentrations than patients with SUD but not comorbid MDD or controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In contrast, patients with MDD but not SUD showed no differences compared with their controls. The negative association between G-CSF concentrations and age in the sample was not observed in patients with MDD. G-CSF concentrations were decreased in patients with SUD and comorbid MDD but not in patients with MDD. Therefore, G-CSF may be useful to improve the stratification of patients with dual diagnosis seeking treatment. Further investigation is needed to explore the impact of sex and type of drug on the expression of G-CSF.<\/jats:p>","DOI":"10.1038\/s41598-021-93075-1","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T10:05:24Z","timestamp":1625133924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder"],"prefix":"10.1038","volume":"11","author":[{"given":"Sandra Torres","family":"Galv\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Flores-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Romero-Sanchiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Requena-Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Porras-Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Nogueira-Arjona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferm\u00edn","family":"Mayoral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Araos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Muga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Garc\u00eda-Marchena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Rodr\u00edguez","family":"de Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"93075_CR1","volume-title":"Global Status Report on Alcohol and Health on Alcohol and Health","author":"WHO","year":"2021","unstructured":"WHO. Global Status Report on Alcohol and Health on Alcohol and Health (World Health Organization, 2021)."},{"key":"93075_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","volume":"39","author":"LJ Lawson","year":"1990","unstructured":"Lawson, L. J., Perry, V. H., Dri, P. & Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151\u2013170 (1990).","journal-title":"Neuroscience"},{"key":"93075_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/npp.2016.121","volume":"42","author":"MJ Lacagnina","year":"2017","unstructured":"Lacagnina, M. J., Rivera, P. D. & Bilbo, S. D. Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology 42, 156\u2013177 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"93075_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187634","volume":"12","author":"N Garcia-Marchena","year":"2017","unstructured":"Garcia-Marchena, N. et al. Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders. PLoS ONE 12, e0187634. https:\/\/doi.org\/10.1371\/journal.pone.0187634 (2017).","journal-title":"PLoS ONE"},{"key":"93075_CR5","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1523\/JNEUROSCI.22-09-03332.2002","volume":"22","author":"F Weiss","year":"2002","unstructured":"Weiss, F. & Porrino, L. J. Behavioral neurobiology of alcohol addiction: Recent advances and challenges. J. Neurosci. 22, 3332\u20133337 (2002).","journal-title":"J. Neurosci."},{"key":"93075_CR6","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.1523\/JNEUROSCI.3063-04.2004","volume":"24","author":"K Nixon","year":"2004","unstructured":"Nixon, K. & Crews, F. T. Temporally specific burst in cell proliferation increases hippocampal neurogenesis in protracted abstinence from alcohol. J. Neurosci. 24, 9714\u20139722 (2004).","journal-title":"J. Neurosci."},{"key":"93075_CR7","first-page":"2","volume":"2","author":"M Kohno","year":"2019","unstructured":"Kohno, M. et al. Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies. Pharmacol. Biochem. Behav. 2, 2 (2019).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"93075_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.pharmthera.2012.01.008","volume":"134","author":"JK Coller","year":"2012","unstructured":"Coller, J. K. & Hutchinson, M. R. Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Pharmacol. Ther. 134, 219\u2013245 (2012).","journal-title":"Pharmacol. Ther."},{"key":"93075_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3346\/jkms.2009.24.5.941","volume":"24","author":"YK Kim","year":"2009","unstructured":"Kim, Y. K. et al. Increased transforming growth factor-beta1 in alcohol dependence. J. Korean Med. Sci. 24, 941\u2013944. https:\/\/doi.org\/10.3346\/jkms.2009.24.5.941 (2009).","journal-title":"J. Korean Med. Sci."},{"key":"93075_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1006\/cyto.2000.0715","volume":"12","author":"A Gonzalez-Quintela","year":"2000","unstructured":"Gonzalez-Quintela, A. et al. Influence of acute alcohol intake and alcohol withdrawal on circulating levels of IL-6, IL-8, IL-10 and IL-12. Cytokine 12, 1437\u20131440. https:\/\/doi.org\/10.1006\/cyto.2000.0715 (2000).","journal-title":"Cytokine"},{"key":"93075_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.pnpbp.2010.05.025","volume":"34","author":"A Heberlein","year":"2010","unstructured":"Heberlein, A. et al. BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 1060\u20131064. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.05.025 (2010).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"93075_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.expneurol.2007.11.017","volume":"210","author":"J He","year":"2008","unstructured":"He, J. & Crews, F. T. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp. Neurol. 210, 349\u2013358 (2008).","journal-title":"Exp. Neurol."},{"key":"93075_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbr.2005.06.026","volume":"165","author":"YA Blednov","year":"2005","unstructured":"Blednov, Y. A. et al. Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol. Behav. Brain Res. 165, 110\u2013125 (2005).","journal-title":"Behav. Brain Res."},{"key":"93075_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fpsyt.2016.00214","volume":"7","author":"N Garcia-Marchena","year":"2016","unstructured":"Garcia-Marchena, N. et al. Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity. Front. Psychiatry 7, 214. https:\/\/doi.org\/10.3389\/fpsyt.2016.00214 (2016).","journal-title":"Front. Psychiatry"},{"key":"93075_CR15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/adb.12668","volume":"24","author":"D Silva-Pena","year":"2019","unstructured":"Silva-Pena, D. et al. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats. Addict. Biol. 24, 1019\u20131033. https:\/\/doi.org\/10.1111\/adb.12668 (2019).","journal-title":"Addict. Biol."},{"key":"93075_CR16","doi-asserted-by":"crossref","unstructured":"Degenhardt, L. et al. The global epidemiology and burden of opioid dependence: Results from the Global Burden of Disease 2010 study. Vol. 109 (2014).","DOI":"10.1111\/add.12551"},{"key":"93075_CR17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1073\/pnas.1524860113","volume":"113","author":"P Guha","year":"2016","unstructured":"Guha, P., Harraz, M. M. & Snyder, S. H. Cocaine elicits autophagic cytotoxicity via a nitric oxide-GAPDH signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 113, 1417\u20131422. https:\/\/doi.org\/10.1073\/pnas.1524860113 (2016).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"93075_CR18","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1523\/jneurosci.4652-15.2016","volume":"36","author":"CA Siciliano","year":"2016","unstructured":"Siciliano, C. A., Fordahl, S. C. & Jones, S. R. Cocaine self-administration produces long-lasting alterations in dopamine transporter responses to cocaine. J. Neurosci. 36, 7807\u20137816. https:\/\/doi.org\/10.1523\/jneurosci.4652-15.2016 (2016).","journal-title":"J. Neurosci."},{"key":"93075_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrn.2016.39","volume":"17","author":"ME Wolf","year":"2016","unstructured":"Wolf, M. E. Synaptic mechanisms underlying persistent cocaine craving. Nat. Rev. Neurosci. 17, 351\u2013365. https:\/\/doi.org\/10.1038\/nrn.2016.39 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"93075_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/hup.1251","volume":"27","author":"HC Fox","year":"2012","unstructured":"Fox, H. C. et al. Immune system inflammation in cocaine dependent individuals: Implications for medications development. Hum. Psychopharmacol. 27, 156\u2013166. https:\/\/doi.org\/10.1002\/hup.1251 (2012).","journal-title":"Hum. Psychopharmacol."},{"key":"93075_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/adb.12156","volume":"20","author":"P Araos","year":"2015","unstructured":"Araos, P. et al. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: Influence of cocaine symptom severity and psychiatric co-morbidity. Addict. Biol. 20, 756\u2013772. https:\/\/doi.org\/10.1111\/adb.12156 (2015).","journal-title":"Addict. Biol."},{"key":"93075_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.20882\/adicciones.933","volume":"29","author":"M Torrens","year":"2017","unstructured":"Torrens, M., Mestre-Pinto, J.-I., Montanari, L., Vicente, J. & Domingo-Salvany, A. Patolog\u00eda dual: una perspectiva europea Dual diagnosis: An European perspective. Adicciones 29, 3\u20135 (2017).","journal-title":"Adicciones"},{"key":"93075_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/archpsyc.64.7.830","volume":"64","author":"DS Hasin","year":"2007","unstructured":"Hasin, D. S., Stinson, F. S., Ogburn, E. & Grant, B. F. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 64, 830\u2013842. https:\/\/doi.org\/10.1001\/archpsyc.64.7.830 (2007).","journal-title":"Arch. Gen. Psychiatry"},{"key":"93075_CR24","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.biopsych.2004.06.034","volume":"56","author":"RC Kessler","year":"2004","unstructured":"Kessler, R. C. The epidemiology of dual diagnosis. Biol. Psychiat. 56, 730\u2013737 (2004).","journal-title":"Biol. Psychiat."},{"key":"93075_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1176\/appi.ajp.2012.12010112","volume":"170","author":"HM Pettinati","year":"2013","unstructured":"Pettinati, H. M., O\u2019Brien, C. P. & Dundon, W. D. Current status of co-occurring mood and substance use disorders: A new therapeutic target. Am. J. Psychiatry 170, 23\u201330 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"93075_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.20882\/adicciones.728","volume":"29","author":"N Garcia Marchena","year":"2016","unstructured":"Garcia Marchena, N. et al. Psychiatric comorbidity and plasma levels of 2-acyl-glycerols in outpatient treatment alcohol users. Analysis of gender differences. Adicciones 29, 83\u201396. https:\/\/doi.org\/10.20882\/adicciones.728 (2016).","journal-title":"Adicciones"},{"key":"93075_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/02791072.2017.1342151","volume":"49","author":"P Araos","year":"2017","unstructured":"Araos, P. et al. Differences in the rates of drug polyconsumption and psychiatric comorbidity among patients with cocaine use disorders according to the mental health service. J. Psychoactive Drugs 49, 306\u2013315. https:\/\/doi.org\/10.1080\/02791072.2017.1342151 (2017).","journal-title":"J. Psychoactive Drugs"},{"key":"93075_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","volume":"72","author":"E Setiawan","year":"2015","unstructured":"Setiawan, E. et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiat. 72, 268\u2013275 (2015).","journal-title":"JAMA Psychiat."},{"key":"93075_CR29","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00213-016-4214-0","volume":"233","author":"A Bhattacharya","year":"2016","unstructured":"Bhattacharya, A., Derecki, N. C., Lovenberg, T. W. & Drevets, W. C. Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology 233, 1623\u20131636 (2016).","journal-title":"Psychopharmacology"},{"key":"93075_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.pharep.2019.05.022","volume":"71","author":"M Kowalczyk","year":"2019","unstructured":"Kowalczyk, M. et al. An immune gate of depression\u2014Early neuroimmune development in the formation of the underlying depressive disorder. Pharmacol. Rep. 71, 1299\u20131307. https:\/\/doi.org\/10.1016\/j.pharep.2019.05.022 (2019).","journal-title":"Pharmacol. Rep."},{"key":"93075_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020066","author":"M Ga\u0142ecka","year":"2021","unstructured":"Ga\u0142ecka, M. et al. Inflammatory versus anti-inflammatory profiles in major depressive disorders-the role of IL-17, IL-21, IL-23, IL-35 and Foxp3. J. Person. Med. https:\/\/doi.org\/10.3390\/jpm11020066 (2021).","journal-title":"J. Person. Med."},{"key":"93075_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s43440-020-00202-2","volume":"73","author":"M Ga\u0142ecka","year":"2021","unstructured":"Ga\u0142ecka, M., Bli\u017aniewska-Kowalska, K., Maes, M., Su, K. P. & Ga\u0142ecki, P. Update on the neurodevelopmental theory of depression: Is there any \u201cunconscious code\u201d?. Pharmacol. Rep. PR 73, 346\u2013356. https:\/\/doi.org\/10.1007\/s43440-020-00202-2 (2021).","journal-title":"Pharmacol. Rep. PR"},{"key":"93075_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/978-3-642-70385-0_82","volume-title":"Modern Trends in Human Leukemia VI New Results in Clinical and Biological Research Including Pediatric Oncology","author":"K Welte","year":"1985","unstructured":"Welte, K. et al. Modern Trends in Human Leukemia VI New Results in Clinical and Biological Research Including Pediatric Oncology 398\u2013401 (Springer, 1985)."},{"key":"93075_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainres.2005.07.076","volume":"1058","author":"S-T Lee","year":"2005","unstructured":"Lee, S.-T. et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res. 1058, 120\u2013128 (2005).","journal-title":"Brain Res."},{"key":"93075_CR35","doi-asserted-by":"crossref","unstructured":"Metcalf, D. et al. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor.  Blood\n. 67(1):37\u201345 (1986).","DOI":"10.1182\/blood.V67.1.37.37"},{"key":"93075_CR36","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1172\/JCI23559","volume":"115","author":"A Schneider","year":"2005","unstructured":"Schneider, A. et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Investig. 115, 2083\u20132098 (2005).","journal-title":"J. Clin. Investig."},{"key":"93075_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1471-4159.2006.03727.x","volume":"97","author":"K Meuer","year":"2006","unstructured":"Meuer, K. et al. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson\u2019s disease. J. Neurochem. 97, 675\u2013686 (2006).","journal-title":"J. Neurochem."},{"key":"93075_CR38","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1084\/jem.20062481","volume":"204","author":"K-J Tsai","year":"2007","unstructured":"Tsai, K.-J., Tsai, Y.-C. & Shen, C.-K.J. G-CSF rescues the memory impairment of animal models of Alzheimer\u2019s disease. J. Exp. Med. 204, 1273\u20131280 (2007).","journal-title":"J. Exp. Med."},{"key":"93075_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.pnpbp.2010.03.033","volume":"34","author":"SM Lehto","year":"2010","unstructured":"Lehto, S. M. et al. Serum IL-7 and G-CSF in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 34, 846\u2013851. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.03.033 (2010).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"93075_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-01881-x","volume":"9","author":"ES Calipari","year":"2018","unstructured":"Calipari, E. S. et al. Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine. Nat. Commun. 9, 1\u201314 (2018).","journal-title":"Nat. Commun."},{"key":"93075_CR41","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/add.15160","volume":"115","author":"ZX Wei","year":"2020","unstructured":"Wei, Z. X., Chen, L., Zhang, J. J. & Cheng, Y. Aberrations in peripheral inflammatory cytokine levels in substance use disorders: a meta-analysis of 74 studies. Addiction 115, 2257\u20132267. https:\/\/doi.org\/10.1111\/add.15160 (2020).","journal-title":"Addiction"},{"key":"93075_CR42","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.chc.2015.11.007","volume":"25","author":"SR LeNoue","year":"2016","unstructured":"LeNoue, S. R. & Riggs, P. D. Substance abuse prevention. Child Adolescent Psychiatric Clin. 25, 297\u2013305 (2016).","journal-title":"Child Adolescent Psychiatric Clin."},{"key":"93075_CR43","unstructured":"APA. DSM-IV-TR: Diagnostic and statistical manual of mental disorders, text revision. Washington, DC: American Psychiatric Association 75, 78\u201385 (2000)."},{"key":"93075_CR44","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1176\/appi.ajp.161.7.1231","volume":"161","author":"M Torrens","year":"2004","unstructured":"Torrens, M., Serrano, D., Astals, M., Perez-Dominguez, G. & Martin-Santos, R. Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am. J. Psychiatry 161, 1231\u20131237. https:\/\/doi.org\/10.1176\/appi.ajp.161.7.1231 (2004).","journal-title":"Am. J. Psychiatry"},{"key":"93075_CR45","doi-asserted-by":"crossref","unstructured":"Beck, A., Steer, R. & Brown, G. Manual for the Beck depression inventory-II. 1996. San Antonio, TX: Psychological Corporation 2 (1996).","DOI":"10.1037\/t00742-000"},{"key":"93075_CR46","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1176\/ajp.2006.163.4.689","volume":"163","author":"D Hasin","year":"2006","unstructured":"Hasin, D. et al. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am. J. Psychiatry 163, 689\u2013696. https:\/\/doi.org\/10.1176\/ajp.2006.163.4.689 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"93075_CR47","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archpsyc.1988.01800360017003","volume":"45","author":"LN Robins","year":"1988","unstructured":"Robins, L. N. et al. The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry 45, 1069\u20131077 (1988).","journal-title":"Arch. Gen. Psychiatry"},{"key":"93075_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuropharm.2019.02.026","volume":"149","author":"P Romero-Sanchiz","year":"2019","unstructured":"Romero-Sanchiz, P. et al. Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. Neuropharmacology 149, 212\u2013220. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.02.026 (2019).","journal-title":"Neuropharmacology"},{"key":"93075_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3233\/jad-2009-1017","volume":"17","author":"C Laske","year":"2009","unstructured":"Laske, C., Stellos, K., Stransky, E., Leyhe, T. & Gawaz, M. Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. JAD 17, 115\u2013123. https:\/\/doi.org\/10.3233\/jad-2009-1017 (2009).","journal-title":"J. Alzheimer's Dis. JAD"},{"key":"93075_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray, S. et al. Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359\u20131362. https:\/\/doi.org\/10.1038\/nm1653 (2007).","journal-title":"Nat. Med."},{"key":"93075_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob, G. F. & Le Moal, M. Drug abuse: Hedonic homeostatic dysregulation. Science 278, 52\u201358. https:\/\/doi.org\/10.1126\/science.278.5335.52 (1997).","journal-title":"Science"},{"key":"93075_CR52","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.aohep.2019.04.005","volume":"18","author":"JP Arab","year":"2019","unstructured":"Arab, J. P. et al. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH). Ann. Hepatol. 18, 518\u2013535. https:\/\/doi.org\/10.1016\/j.aohep.2019.04.005 (2019).","journal-title":"Ann. Hepatol."},{"key":"93075_CR53","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1177\/0269881120928176","volume":"34","author":"N Garc\u00eda-Marchena","year":"2020","unstructured":"Garc\u00eda-Marchena, N. et al. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases. J. Psychopharmacol. (Oxford, Engl.) 34, 1250\u20131260. https:\/\/doi.org\/10.1177\/0269881120928176 (2020).","journal-title":"J. Psychopharmacol. (Oxford, Engl.)"},{"key":"93075_CR54","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/adb.12408","volume":"22","author":"N Garcia-Marchena","year":"2017","unstructured":"Garcia-Marchena, N. et al. Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: Effect of length of abstinence. Addict. Biol. 22, 1366\u20131377. https:\/\/doi.org\/10.1111\/adb.12408 (2017).","journal-title":"Addict. Biol."},{"key":"93075_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11920-015-0625-6","volume":"17","author":"NC Westfall","year":"2015","unstructured":"Westfall, N. C. & Nemeroff, C. B. The preeminence of early life trauma as a risk factor for worsened long-term health outcomes in women. Curr. Psychiatry Rep. 17, 90 (2015).","journal-title":"Curr. Psychiatry Rep."},{"key":"93075_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJ Schiepers","year":"2005","unstructured":"Schiepers, O. J., Wichers, M. C. & Maes, M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 201\u2013217 (2005).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"93075_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213791","volume":"14","author":"N Garcia-Marchena","year":"2019","unstructured":"Garcia-Marchena, N. et al. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders. PLoS ONE 14, e0213791. https:\/\/doi.org\/10.1371\/journal.pone.0213791 (2019).","journal-title":"PLoS ONE"},{"key":"93075_CR58","doi-asserted-by":"crossref","unstructured":"Diederich, K. et al. Synergetic effects of granulocyte-colony stimulating factor and cognitive training on spatial learning and survival of newborn hippocampal neurons. PLOS one 4 (2009).","DOI":"10.1371\/journal.pone.0005303"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93075-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93075-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93075-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:32:58Z","timestamp":1670063578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-93075-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["93075"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-93075-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"21 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13629"}}